Radionetics Oncology
PrivateLast Round
Strategic
Jul 1, 2024
Est. Valuation
$60.61M
Total Funding Raised
$222.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Radionetics Oncology is a biopharmaceutical company that discovers and develops novel small-molecule radiopharmaceuticals targeting G-protein coupled receptors for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Radionetics Oncology Comparables
Compare Radionetics Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alpha-9 Oncology | 90% | |
| Abdera Therapeutics | 89% | |
| Ratio Therapeutics Inc. | 85% | |
Radionetics Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 1, 2024 | ||||
| Series A | Jan 3, 2024 | ||||
| Seed | Oct 18, 2021 |
Key People
Founding team and executive leadership
Radionetics Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frazier Healthcare Partners | Seed |
| DCVC Bio | Series A |
| GordonMD Global Investments | Series A |
| 5AM Ventures | Series A, Seed |
| Frazier Life Sciences | Series A |
| DCVC (Data Collective) | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 11, 2026
Announced a strategic agreement with Eli Lilly.
- Jan 3, 2024
$53M round completed.
Radionetics Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Radionetics Oncology's valuation, stock price, and market status.